Literature DB >> 14660396

Characterization of Vibrio fluvialis-like strains implicated in limp lobster disease.

B D Tall1, S Fall, M R Pereira, M Ramos-Valle, S K Curtis, M H Kothary, D M T Chu, S R Monday, L Kornegay, T Donkar, D Prince, R L Thunberg, K A Shangraw, D E Hanes, F M Khambaty, K A Lampel, J W Bier, R C Bayer.   

Abstract

Studies were undertaken to characterize and determine the pathogenic mechanisms involved in a newly described systemic disease in Homarus americanus (American lobster) caused by a Vibrio fluvialis-like microorganism. Nineteen isolates were obtained from eight of nine lobsters sampled. Biochemically, the isolates resembled V. fluvialis, and the isolates grew optimally at 20 degrees C; none could grow at temperatures above 23 degrees C. The type strain (1AMA) displayed a thermal reduction time (D value) of 5.77 min at 37 degrees C. All of the isolates required at least 1% NaCl for growth. Collectively, the data suggest that these isolates may embody a new biotype. Pulsed-field gel electrophoresis (PFGE) analysis of the isolates revealed five closely related subgroups. Some isolates produced a sheep hemagglutinin that was neither an outer membrane protein nor a metalloprotease. Several isolates possessed capsules. The isolates were highly susceptible to a variety of antibiotics tested. However, six isolates were resistant to erythromycin. Seventeen isolates harbored plasmids. Lobster challenge studies revealed that the 50% lethal dose of a plasmid-positive strain was 100-fold lower than that of a plasmid-negative strain, suggesting that the plasmid may enhance the pathogenicity of these microorganisms in lobsters. Microorganisms that were recovered from experimentally infected lobsters exhibited biochemical and PFGE profiles that were indistinguishable from those of the challenge strain. Tissue affinity studies demonstrated that the challenge microorganisms accumulated in heart and midgut tissues as well as in the hemolymph. Culture supernatants and polymyxin B lysates of the strains caused elongation of CHO cells in tissue culture, suggesting the presence of a hitherto unknown enterotoxin. Both plasmid-positive and plasmid-negative strains caused significant dose-related intestinal fluid accumulations in suckling mice. Absence of viable organisms in the intestinal contents of mice suggests that these microorganisms cause diarrhea in mice by intoxication rather than by an infectious process. Further, these results support the thermal reduction data at 37 degrees C and suggest that the mechanism(s) that led to fluid accumulation in mice differs from the disease process observed in lobsters by requiring neither the persistence of viable microorganisms nor the presence of plasmids. In summary, results of lobster studies satisfy Koch's postulates at the organismal and molecular levels; the findings support the hypothesis that these V. fluvialis-like organisms were responsible for the originally described systemic disease, which is now called limp lobster disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660396      PMCID: PMC309894          DOI: 10.1128/AEM.69.12.7435-7446.2003

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  60 in total

1.  Purification and characterization of a vulnificolysin-like cytolysin produced by Vibrio tubiashii.

Authors:  M H Kothary; R B Delston; S K Curtis; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

2.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

3.  Isolation and characterization of rugose form of Vibrio cholerae O139 strain MO10.

Authors:  Y Mizunoe; S N Wai; A Takade; S I Yoshida
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Thermal-death times of opaque and translucent morphotypes of Vibrio vulnificus.

Authors:  C M Kim; K C Jeong; J H Rhee; S H Choi
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Multiple Vibrio vulnificus strains in oysters as demonstrated by clamped homogeneous electric field gel electrophoresis.

Authors:  C Buchrieser; V V Gangar; R L Murphree; M L Tamplin; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1995-03       Impact factor: 4.792

7.  Evaluation of Hawaiian green turtles (Chelonia mydas) for potential pathogens associated with fibropapillomas.

Authors:  A A Aguirre; G H Balazs; B Zimmerman; T R Spraker
Journal:  J Wildl Dis       Date:  1994-01       Impact factor: 1.535

8.  Rapid serological identification of Vibrio vulnificus by anti-H coagglutination.

Authors:  J Simonson; R J Siebeling
Journal:  Appl Environ Microbiol       Date:  1986-12       Impact factor: 4.792

9.  Purification and characterization of enterotoxigenic El Tor-like hemolysin produced by Vibrio fluvialis.

Authors:  Mahendra H Kothary; Heather Lowman; Barbara A McCardell; Ben D Tall
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Plasmid carriage in Vibrio vulnificus and other lactose-fermenting marine vibrios.

Authors:  L S Davidson; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1986-07       Impact factor: 4.792

View more
  9 in total

1.  Fishing diseased abalone to promote yield and conservation.

Authors:  Tal Ben-Horin; Kevin D Lafferty; Gorka Bidegain; Hunter S Lenihan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-03-05       Impact factor: 6.237

2.  Identification of genetic bases of vibrio fluvialis species-specific biochemical pathways and potential virulence factors by comparative genomic analysis.

Authors:  Xin Lu; Weili Liang; Yunduan Wang; Jialiang Xu; Jun Zhu; Biao Kan
Journal:  Appl Environ Microbiol       Date:  2014-01-17       Impact factor: 4.792

3.  Rugosity in Grimontia hollisae.

Authors:  S K Curtis; M H Kothary; R J Blodgett; R B Raybourne; G C Ziobro; B D Tall
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

4.  Accurate Identification of Diverse N-acyl Homoserine Lactones in Marine Vibrio fluvialis by UHPLC-MS/MS.

Authors:  Jingjiao Bao; Dengkang Guo; Lei Jin; Tiejun Li; Hui Shi
Journal:  Curr Microbiol       Date:  2022-05-05       Impact factor: 2.188

5.  VfqI-VfqR quorum sensing circuit modulates type VI secretion system VflT6SS2 in Vibrio fluvialis.

Authors:  Yu Han; Jingjing Pan; Yuanming Huang; Qian Cheng; Ping Liu; Baowei Diao; Jie Li; Biao Kan; Weili Liang
Journal:  Biochem Biophys Rep       Date:  2022-06-02

6.  Anti-lipopolysaccharide factors in the American lobster Homarus americanus: molecular characterization and transcriptional response to Vibrio fluvialis challenge.

Authors:  K M Beale; D W Towle; N Jayasundara; C M Smith; J D Shields; H J Small; S J Greenwood
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2008-12       Impact factor: 2.674

7.  Epidemiologic potentials and correlational analysis of Vibrio species and virulence toxins from water sources in greater Bushenyi districts, Uganda.

Authors:  Hope Onohuean; Anthony I Okoh; Uchechukwu U Nwodo
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

8.  The virulence phenotypes and molecular epidemiological characteristics of Vibrio fluvialis in China.

Authors:  Pu Liang; Xiaoying Cui; Xiaoli Du; Biao Kan; Weili Liang
Journal:  Gut Pathog       Date:  2013-03-22       Impact factor: 4.181

9.  Occurrence of Vibrio pathotypes in the final effluents of five wastewater treatment plants in Amathole and Chris Hani District Municipalities in South Africa.

Authors:  Vuyokazi Nongogo; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2014-08-04       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.